<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:mpath ids='MPATH_653'>Langerhans cell histiocytosis</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LCH</z:e>) in adults first presenting in the skin is rare </plain></SENT>
<SENT sid="1" pm="."><plain>Guidelines for staging, treatment and follow-up are lacking </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVES: To better define staging procedures, treatment results and clinical course in adult patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LCH</z:e> first presenting in the skin </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Eighteen adult patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LCH</z:e> first presenting in the skin were collected from five centres collaborating in the Dutch Cutaneous <z:hpo ids='HP_0002665'>Lymphoma</z:hpo> Group </plain></SENT>
<SENT sid="4" pm="."><plain>Clinical records and (skin) biopsy specimens were reviewed and follow-up data were obtained </plain></SENT>
<SENT sid="5" pm="."><plain>A literature search on adult patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LCH</z:e> presenting in the skin was performed </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Staging procedures showed extracutaneous disease in three of 16 patients who were adequately staged </plain></SENT>
<SENT sid="7" pm="."><plain>One patient had a histologically confirmed lytic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LCH</z:e> <z:e sem="disease" ids="C0238792" disease_type="Disease or Syndrome" abbrv="">bone lesion</z:e>, while two patients had a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>During follow-up two of 18 patients developed extracutaneous localizations of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LCH</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Five patients developed a second <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">haematological malignancy</z:e>, including (myelo)<z:mpath ids='MPATH_502'>monocytic leukaemia</z:mpath> (two cases), histiocytic <z:hpo ids='HP_0100242'>sarcoma</z:hpo> (one case), diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (one case) and peripheral T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (one case) </plain></SENT>
<SENT sid="10" pm="."><plain>Review of the literature revealed six other adult patients with a second <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">haematological malignancy</z:e> preceding or following a diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LCH</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: The results of the present study suggest an increased risk of a second <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">haematological malignancy</z:e> in adult patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LCH</z:e> presenting in the skin </plain></SENT>
<SENT sid="12" pm="."><plain>Extensive staging at presentation and long-term follow-up are therefore warranted in such patients </plain></SENT>
</text></document>